Early cardiac inflammation as a driver of murine model of Arrhythmogenic Cardiomyopathy
K.-E. Ng, P. J. Delaney, D. Thenet, S. Murtough, C. M. Webb, E. Tsisanova, S. L. Walker, J. D. Westaby, D. J. Pennington, R. Pink, D. P. Kelsell, A. Tinker
Abstract
The study of a desmoglein 2 murine model of arrhythmogenic cardiomyopathy revealed cardiac inflammation as a key early event leading to fibrosis. Arrhythmogenic Cardiomyopathy (AC) is an inherited heart muscle disorder leading to ventricular arrhythmias and heart failure due to abnormalities in the cardiac desmosome. We examined how loss of desmoglein 2 (Dsg2) in the young murine heart leads to development of AC. Cardiomyocyte apoptosis was an early cellular phenotype and RNA-Seq analysis revealed early activation of inflammatory-associated pathways in Dsg2 null (Dsg2−/−) hearts at postnatal day 14 (Two weeks) that were absent in the fibrotic heart of adult mice (Ten weeks). This included upregulation of iRhom2/ADAM17 and its associated pro-inflammatory cytokines and receptors such as TNFα, IL6R and IL-6. Furthermore, genes linked to specific macrophage populations were upregulated. This suggests cardiomyocyte stress triggers an early immune response to clear apoptotic cells allowing tissue remodelling later on in the fibrotic heart. Our analysis at different disease stages implicate inflammation related to loss of desmoglein 2 as a major mechanism for disease progression.View Full Text
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechanisms of Innate Immune Injury in Arrhythmogenic Cardiomyopathy
S. P. Chelko, V. Penna, … J. E. Saffitz·bioRxiv·Jul 12, 2023
- Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by involving an Integrin-αVβ6/TGF-β Signaling Cascade
C. Schinner, H. Franz, … V. Spindler·bioRxiv·Sep 2, 2021
- Interleukin-1β Drives Disease Progression in Arrhythmogenic Cardiomyopathy
Vinay R. Penna, Junedh Amrute, … Stephen P. Chelko·JACC Basic to Translational SciencePeer-reviewed·May 5, 2026
- NETosis and Myeloperoxidase Promotes Inflammation and Cardiac Remodeling in Arrhythmogenic Cardiomyopathy
Emily Shiel, Gallage H. D. Nipun Ariyaratne, … Stephen P. Chelko·bioRxiv·Apr 17, 2026
- CD14 Blockade Attenuates Arrhythmogenic Cardiomyopathy
Vinay R. Penna, Emily A. Shiel, … Kory J. Lavine·bioRxiv·Oct 7, 2026
- Epicardial contributions to fibro-inflammatory signaling in a Pkp2-deficient arrhythmogenic cardiomyopathy model
Daniel D Han, Alan C. Brooks, … Eric M. Small·Circulation Heart FailurePeer-reviewed·Jun 5, 2026